Robert G. Finizio, CEO at TherapeuticsMD, Inc. (TXMD), sold 368,000 shares at $4.81 ($1.8M) on 2018-11-27, disclosed to the SEC on 2018-11-28.
Open-market sale of $1.8M TXMD by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.86 | 92,000 | $447K | 25.1% |
| 2 | $4.86 | 92,000 | $447K | 25.1% |
| 3 | $4.81 | 92,000 | $443K | 24.9% |
| 4 | $4.81 | 92,000 | $443K | 24.9% |
| Total | $4.83 avg | 368,000 | $1.8M | 100% |
| Filing → |
| TXMD | BUY | 2020-06-08 | $35K | — | Filing → |
| TXMD | BUY | 2019-10-29 | $198K | — | Filing → |
| TXMD | BUY | 2019-08-20 | $192K | — | Filing → |